| ORIGINAL ARTICLES |
|
| Year : 2022 | Volume
: 2
| Issue : 1 | Page : 35-39 |
|
|
COVID-19 pandemic: Interaction of lockdown with liver disease and metabolic parameters
Chitranshu Vashishtha1, Ankit Bhardwaj2, Manoj Kumar Sharma1
1 Department of Hepatology, Institute of Liver & Biliary Sciences, New Delhi, India
2 Clinical Research Department, Institute of Liver & Biliary Sciences, New Delhi, India
Correspondence Address:
Chitranshu Vashishtha
Department of Hepatology, Institute of Liver & Biliary Sciences, New Delhi
India
 Source of Support: None, Conflict of Interest: None
DOI: 10.4103/JCDM.JCDM_4_22
|
|
|
Background: In current COVID-19 pandemic, India had lockdown from 25th March 2020 followed by relaxation in phases from 1st June. The aim of the study was assessment of lockdown impact on metabolic and liver disease status of non-COVID patients of liver diseases. Materials and Methods: OPD data of all consecutive patients of liver disease without COVID-19 infection from 1st January 2020 to 31st December was analyzed. The primary objective was to assess lockdown impact on liver stiffness. Fibroscan, BMI and laboratory data was compared before and after implementation of lockdown in three groups (Group1-noncirrhotics, Group2- compensated cirrhotics, Group3- decompensated cirrhotics). Results: 230 patients (77% M) were analyzed. In all the three groups, there was no significant change in the liver stiffness and fat content by fibroscan, complete blood count, liver and kidney function tests. In Group1, there was significant increase in BMI (25.3 ± 6.0 vs 26.4 ± 6.1, P < 0.01), sugar (mg/dl) fasting (101.5 ± 30.1 vs110.7 ± 31.8, P < 0.01), post prandial (131 ± 31.6 vs 156.5 ± 35.5, P < 0.01), LDL (mg/dl) (111.1 ± 33.1 vs 119.1 ± 26.8, P = 0.036), total lipid/HDL ratio (4.04 ± 1.39 vs 4.58 ± 1.58, P = 0.01) and reduction in HDL (mg/dl) (45.8 ± 12.7 vs 40.4 ± 10.1, P < 0.01). In Group2, significant increase in LDL (97.3 ± 32.5 vs 114.3 ± 29.8, P = 0.01), LDL/HDL ratio (2.36 ± 1.26 vs 2.70 ± 1.03, P = 0.04) and decrease in HDL (45.6 ± 12.1 vs 40.9 ± 11.2, P < 0.01) was seen, with no significant change in BMI, and sugar fasting, post prandial, HbA1c. In Group3, there was no significant change in any of the parameters analysed. Conclusions: There was no impact of lockdown due to Covid pandemic on liver disease status. However, lockdown worsened metabolic parameters of non-cirrhotics and compensated cirrhotics. |
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
Next article
